Great West Life Assurance CO Stoke Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 11,349 shares of STOK stock, worth $128,811. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,349
Previous 10,043
13.0%
Holding current value
$128,811
Previous $135,000
3.7%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding STOK
# of Institutions
129Shares Held
55.6MCall Options Held
9.3KPut Options Held
35.2K-
Skorpios Trust6.91MShares$78.4 Million99.8% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$61.4 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$58.9 Million22.82% of portfolio
-
Redmile Group, LLC San Francisco, CA4.71MShares$53.5 Million3.79% of portfolio
-
Rtw Investments, LP New York, NY4.65MShares$52.8 Million0.91% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $447M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...